2024
|
G/S
|
Drug delivery agents in the form of dissolvable or erodible films that facilitate the oral, trans... |
2023
|
Invention
|
Film formulations containing dexmedetomidine and methods of producing them.
Disclosed herein is ... |
|
Invention
|
Dispensing method for producing dissolvable unit dose film constructs. Dissolvable unit dose film... |
|
Invention
|
Transdermal delivery systems for certain factor xa inhibitors and related methods for their prepa... |
2020
|
Invention
|
Non-sedating dexmedetomidine treatment regimens.
Disclosed herein are methods of administering r... |
|
Invention
|
Non-sedating dexmedetomidine treatment regimens. Disclosed herein are methods of administering re... |
2019
|
Invention
|
Dispensing method for producing dissolvable unit dose film constructs. Dissolvable unit dos... |
|
Invention
|
Film formulations containing dexmedetomidine and methods of producing them. Disclosed herein is a... |
2017
|
Invention
|
Production of unit dose constructs. A method of forming a kit containing multiple dissolvable uni... |
|
Invention
|
Production of unit dose constructs.
Dissolvable unit dose constructs and their method of manufac... |
2016
|
Invention
|
Production of unit dose constructs. Dissolvable unit dose constructs and their method of manufact... |
2015
|
Invention
|
Method of producing uniform buprenorphine-containing formulations. A method of forming a liquid f... |
|
Invention
|
Method of producing uniform buprenorphine-containing formulations.
A method of forming a liquid ... |
2011
|
Invention
|
Sublingual films. The invention features sublingual film formulations of dopamine agonists and me... |